ATE326972T1 - Heilende zusammensetzung für intraokulare hypertension oder glaukom - Google Patents
Heilende zusammensetzung für intraokulare hypertension oder glaukomInfo
- Publication number
- ATE326972T1 ATE326972T1 AT98945530T AT98945530T ATE326972T1 AT E326972 T1 ATE326972 T1 AT E326972T1 AT 98945530 T AT98945530 T AT 98945530T AT 98945530 T AT98945530 T AT 98945530T AT E326972 T1 ATE326972 T1 AT E326972T1
- Authority
- AT
- Austria
- Prior art keywords
- glaucoma
- healing composition
- intraocular hypertension
- intraocular
- hypertension
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 230000035876 healing Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27854097 | 1997-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326972T1 true ATE326972T1 (de) | 2006-06-15 |
Family
ID=17598695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98945530T ATE326972T1 (de) | 1997-10-13 | 1998-09-30 | Heilende zusammensetzung für intraokulare hypertension oder glaukom |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6329426B1 (de) |
| EP (1) | EP0979652B1 (de) |
| AT (1) | ATE326972T1 (de) |
| CA (1) | CA2274708A1 (de) |
| DE (1) | DE69834638T2 (de) |
| DK (1) | DK0979652T3 (de) |
| ES (1) | ES2265166T3 (de) |
| HK (1) | HK1024170A1 (de) |
| WO (1) | WO1999018969A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000038689A1 (fr) * | 1998-12-25 | 2000-07-06 | Sucampo, A.G. | Compositions de medicament pour traiter l'hypertension oculaire ou le glaucome |
| WO2002060387A2 (en) * | 2001-01-30 | 2002-08-08 | Pharmaceutical Research Corporation | Use of prostaglandin analogs for treatment of cardiac conditions |
| DE60326226D1 (de) * | 2002-03-21 | 2009-04-02 | Cayman Chemical Co | Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom |
| AU2003215820A1 (en) * | 2002-03-28 | 2003-10-13 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
| US20020168424A1 (en) * | 2002-07-31 | 2002-11-14 | Dr. Mohsen Shahinpoor | Nitric oxide (NO) donor+cGMP-PDE5 inhibitor as a topical drug for glaucoma |
| US6864282B2 (en) | 2002-08-05 | 2005-03-08 | Allergan, Inc. | 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| US20040225014A1 (en) * | 2003-02-14 | 2004-11-11 | Sucampo Ag | Method for treating ocular hypertension and glaucoma |
| US7320871B2 (en) * | 2003-07-14 | 2008-01-22 | Allergan, Inc. | Human prostaglandin FP receptor variants and methods of using same |
| CN101400354B (zh) * | 2006-03-13 | 2014-10-22 | 株式会社·R-技术上野 | 水性组合物 |
| WO2008120249A1 (en) * | 2007-03-30 | 2008-10-09 | Sifi S.P.A. | Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use |
| EP2127638A1 (de) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom |
| WO2017089980A1 (en) * | 2015-11-26 | 2017-06-01 | Cadila Healthcare Limited | Dual ppar modulators for the treatment of diabetic retinopathy and diabetic eye diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3876050T2 (de) | 1987-09-18 | 1993-03-25 | Ueno Seiyaku Oyo Kenkyujo Kk | Okulare hypotensivagenzien. |
| ES2062102T5 (es) * | 1988-09-06 | 2004-12-01 | Pharmacia Ab | Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular. |
| GB8916944D0 (en) | 1989-07-25 | 1989-09-13 | Ici Plc | Composite particle dispersions |
| EP0561073B1 (de) * | 1992-03-19 | 2001-10-24 | R-Tech Ueno Ltd. | Behandlung von Augenhochdruck mit Betablockern und Prostansäurederivaten |
| AU665287B2 (en) * | 1992-12-21 | 1995-12-21 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| AU7680096A (en) * | 1995-12-22 | 1997-07-17 | Alcon Laboratories, Inc. | Combinations of dp and fp type prostaglandins for lowering iop |
-
1998
- 1998-09-30 WO PCT/JP1998/004399 patent/WO1999018969A1/ja active IP Right Grant
- 1998-09-30 DK DK98945530T patent/DK0979652T3/da active
- 1998-09-30 ES ES98945530T patent/ES2265166T3/es not_active Expired - Lifetime
- 1998-09-30 CA CA002274708A patent/CA2274708A1/en not_active Withdrawn
- 1998-09-30 EP EP98945530A patent/EP0979652B1/de not_active Expired - Lifetime
- 1998-09-30 AT AT98945530T patent/ATE326972T1/de not_active IP Right Cessation
- 1998-09-30 DE DE69834638T patent/DE69834638T2/de not_active Expired - Lifetime
- 1998-12-28 US US09/220,847 patent/US6329426B1/en not_active Expired - Lifetime
-
2000
- 2000-06-08 HK HK00103455A patent/HK1024170A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0979652B1 (de) | 2006-05-24 |
| US6329426B1 (en) | 2001-12-11 |
| CA2274708A1 (en) | 1999-04-22 |
| HK1024170A1 (en) | 2000-10-05 |
| DK0979652T3 (da) | 2006-09-11 |
| WO1999018969A1 (fr) | 1999-04-22 |
| EP0979652A1 (de) | 2000-02-16 |
| EP0979652A4 (de) | 2003-05-14 |
| DE69834638D1 (de) | 2006-06-29 |
| DE69834638T2 (de) | 2007-05-10 |
| ES2265166T3 (es) | 2007-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2458493T8 (es) | Composición oftálmica tópica de fluprostenol para el tratamiento del glaucoma y de la hipertensión ocular | |
| MX9702349A (es) | Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma. | |
| ES2193901T1 (es) | Derivados de prostaglandina para el tratamiento de glaucoma o hipertension ocular. | |
| ATE326972T1 (de) | Heilende zusammensetzung für intraokulare hypertension oder glaukom | |
| ATE223200T1 (de) | Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel | |
| AU5355498A (en) | 15-fluoro prostaglandins as ocular hypotensives | |
| ATE216889T1 (de) | Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension | |
| SE9401087D0 (sv) | New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | |
| ATE289198T1 (de) | Verwendung von flunarizin zur topischen behandlung ocularem hochdruck | |
| DE69829227D1 (de) | Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |